BI-MODAL ANALYSIS AGENT
Number of patents in Portfolio can not be more than 2000
United States of America
Stats
-
N/A
Issued Date -
Jan 23, 2020
app pub date -
Jul 18, 2019
filing date -
Jul 18, 2019
priority date (Note) -
Published
status (Latency Note)
Importance
Abstract
Manganese oxide nanoparticles with favorable properties for multi-modal imaging in medical and non-medical imaging applications are provided. The particles are useful for multi-modal magnetic resonance imaging and fluorescence imaging. The particles are useful as T1 contrast agents in magnetic resonance imaging. The favorable properties of the manganese oxide nanoparticles also make them useful as tracers for subsurface formation characterization. One embodiment provides a process which includes the steps of injecting nanoparticles into a discrete subterranean region, and detecting fluorescence and/or magnetic data of the one or more nanoparticles in a produced fluid which includes the injected fluid and a formation fluid from the subterranean region.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully